BioNukleo - Your partner for enzymatic synthesis of nucleoside and nucleotide analogs

BioNukleo, a spin-off of Technische Universität Berlin, is a German biotech company developing new (chemo)enzymatic synthesis routes for nucleic acid derivatives.

 

BioNukleo's technology is based on the use of biocatalysts for the efficient synthesis of nucleic acid derivatives in one-pot and sustainable reactions.

 

Due to its strong competence in the expression of challenging proteins, BioNukleo set up enzyme libraries with wide substrate promiscuity. They allow for the production of a broad range of nucleoside and nucleotide analogs.


Download
Download our flyer here
BioNukleo_Flyer_0619.pdf
Adobe Acrobat Document 2.9 MB